Maryland Stem Cell Research Commission announced today the launch of Accelerating Cure, a new initiative to support regenerative medicine and cell therapy technologies moving from research to commercialization and finally to clinical trials. Accelerating Cure will fund close to $9 million with its five programs to address the different stages the technologies need to go through. The Commission also announced that Dr. Amritha Jaishankar joined the team as the Award Manager for the Maryland Stem Cell Research Fund.
{iframe}http://www.benzinga.com/pressreleases/16/10/p8622043/maryland-stem-cell-research-commission-launches-accelerating-cure{/iframe}